Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Multilingual Wikipedia

In June 2020 the work Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial was on the 805,303rd place in the ranking of the most reliable and popular publications with DOI number in multilingual Wikipedia from readers' point of view (PR-score). If we consider only frequency of appearance of this source in references of Wikipedia articles (F-score), this work was on the 447,450th place in June 2020. From Wikipedians' point of view, "Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial" is the 828,936th most reliable publication with DOI number in different language versions of Wikipedia (AR-score).

PR-score:
805,303rd place
878
+12
AR-score:
828,936th place
156
0
F-score:
447,450th place
2
0

German Wikipedia (de)

PR-score:
57,344th place
607
+97
AR-score:
61,279th place
123
0
F-score:
69,016th place
1
0

Spanish Wikipedia (es)

PR-score:
63,167th place
270
-85
AR-score:
65,344th place
32
0
F-score:
52,740th place
1
0

BestRef shows popularity and reliability scores for sources in references of Wikipedia articles in different languages. Data extraction based on complex method using Wikimedia dumps. To find the most popular and reliable sources we used information about over 200 million references of Wikipedia articles. More details...